Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
NVO News
Bernie Sanders said the CEO of Novo Nordisk will testify on the cost of Ozempic and Wegovy. Lars Jørgensen will appear before the Senate Committee on Health, E...
Madrigal Pharmaceuticals (NASDAQ: MDGL) is in a position that most other biotechs envy. Its first medicine just hit the market, sales are due to start rolling i...
Norvo Nordisk (NVO) (OTCPK:NONOF) has avoided a subpoena for a congressional hearing over its pricing strategy for weight loss drugs, Ozempic and Wegovy, after...
Analyst ratings
67%
of 33 ratingsMore NVO News
Novo Nordisk (NVO) closed the latest trading day at $142.50, indicating a +0.01% change from the previous session's end. The stock outpaced the S&P 500's daily...
(Reuters) -The Senate Committee on Health, Education, Labor, and Pensions said on Friday that Novo Nordisk CEO Lars Jorgensen has agreed to testify voluntarily...
Top growth stocks to watch this week on IBD's Sector Leaders screen include Nvidia (NVDA) stock, as well as Ozempic maker Novo Nordisk (NVO). X Novo Nordisk r...
GLP-1 weight-loss drugs have been major revenue generators for pharmaceutical companies such as Eli Lilly (LLY) and Novo Nordisk (NVO). Goldman Sachs US Lead Bi...
Building an investment portfolio from scratch can be difficult, especially if you're new to investing. It's easy to feel overwhelmed with so many different inve...
Dow Jones futures, along with the other major stock indexes, dropped Friday as Wall Street awaited inflation survey data and consumer confidence numbers. Artifi...
Novo Nordisk's (NYSE: NVO) Wegovy currently reigns as the king of the obesity drug market. It generated roughly $4.5 billion in sales last year and will likely...
